Advancing PFAS biomonitoring: What we measure and why it matters

Wednesday, May 27 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT

This accelerating science forum deep dives into PFAS biomonitoring to protect human health

Register today to secure your virtual front row seat!

As the global conversation around per‑ and polyfluoroalkyl substances (PFAS) moves beyond environmental detection, a new priority has emerged: accurately characterizing human exposure and biological impact. This requires not only understanding toxicological pathways, but also refining how we measure PFAS, which biomarkers matter most, and how analytical workflows shape health‑risk interpretation.

Join our expert panel, including advisors to the Department for Environment, Food and Rural Affairs (DEFRA) and the World Health Organization (WHO), as we bridge cutting‑edge analytical science with real‑world clinical and regulatory decision‑making.

This session will explore:

  • How advances in LC‑MS/MS, HRMS, and multi‑omics are redefining PFAS biomonitoring
  • Which PFAS compounds, metabolites, and exposure biomarkers should be prioritized for meaningful assessment
  • How measurement challenges (e.g. ultra‑trace detection, matrix effects, isomer resolution) directly influence toxicological models and global risk assessment
  • Emerging analytical strategies supporting evidence‑based legislation and population‑level health protection

Who should attend?

  • Analytical chemists developing LC‑MS/MS or HRMS workflows for PFAS exposure and metabolomics
  • Toxicologists and clinical researchers integrating analytical data into metabolic and health‑outcome models
  • Regulatory and EHS (environmental, health, and safety) professionals evaluating PFAS risk in fast-moving consumer goods, cosmetics, and personal care
  • Public health policy makers seeking clarity on which biomarkers and analytical endpoints drive next‑gen legislation

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes

Certificate of attendance

  • If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

This event is just one piece of our Accelerating Science in PFAS series.
See what else is coming up.

Speakers

Dr. Anna Lindell
Dr. Anna Lindell
Speaker
Co-Founder & VP Technology, Cambiotics, Researcher, University of Cambridge
Dr. Mohamed Abdallah
Dr. Mohamed Abdallah
Speaker
Chair in Environmental Chemistry, University of Birmingham
Dr. Luigi Margiotta-Casaluci
Dr. Luigi Margiotta-Casaluci
Speaker
Senior Lecturer in Toxicology, King's College London
Lucy Lawrence
Lucy Lawrence
Moderator
Science Editor, SelectScience

What will this webinar cover?

  • How advances in LC‑MS/MS, HRMS, and multi‑omics are redefining PFAS biomonitoring
  • Which PFAS compounds, metabolites, and exposure biomarkers should be prioritized for meaningful assessment
  • How measurement challenges (e.g. ultra‑trace detection, matrix effects, isomer resolution) directly influence toxicological models and global risk assessment
  • Emerging analytical strategies supporting evidence‑based legislation and population‑level health protection

Tags

Register for free